Therapeutics (TGTX) 2025 Earnings Outlook for Investors
TG Therapeutics faces a pivotal year as it closes 2025 with a tighter focus on its flagship therapeutics portfolio an...
Uncover effective wealth building strategies in tough economic times to ensure your financial success. Start planning today!
19,592 articlesTG Therapeutics faces a pivotal year as it closes 2025 with a tighter focus on its flagship therapeutics portfolio an...
AI investing can feel crowded, but a pair of no-brainer artificial intelligence (ai) stocks stand out for durable gro...
In 2024, medicare paid $12.3 billion for a cluster of services that are now facing tighter coverage. This shift could...
A JPMorgan note argues that a U.S. crypto market structure bill could pass by June and act as a positive catalyst for...
Private and public sector leaders warn that Iran is expanding its AI-enabled cyber toolkit, raising the risk to banks...
Reddit still furious about AT&T's $47 billion write-down lingers as a new buyer group targets the legacy assets for r...
The Pentagon’s fight with Anthropic has become a landmark test of how the U.S. will regulate powerful AI. Markets and...
A leading tech investor envisions a future where AI-enabled labor trims traditional work yet expands access to essent...
AI misinfo is not just a tech issue—it's a real-world risk that can touch markets, portfolios, and lives. This articl...
As Toro prepares to report and discuss its 2026 earnings, investors want clarity on demand, margins, and guidance. Th...
The Pentagon designated Anthropic as a supply-chain risk, triggering an immediate halt to certain contracts and a six...
Oil markets are dictating Bitcoin moves as geopolitical risk deepens, outpacing CPI and ETF factors. Traders say the ...